SMARCA2 and lung cancer: Genomic sequencing studies have indicated that mutations in multiple subunits of the SWI/SNF chromatin-remodelling complex, such as BRG1 or BRM as the catalytic subunit, frequently occurred in numerous solid tumours, including lung cancers.